Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections
- 1 March 1995
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 1 (3) , 267-271
- https://doi.org/10.1038/nm0395-267
Abstract
Human autologous tumour-specific cytotoxic T lymphocytes (CTL) were generated from peripheral blood on small formalin-fixed paraffin-embedded sections of a gastric cancer. The CTL killed live target cells at an effector/target ratio of 1 within 24 hours and showed the same target specificity as those induced on live cancer cells. The killing activity of the CTL lasted for more than four months in culture and was inhibited by antibodies against CD8 and MHC-class I. These results suggest that adoptive immunotherapy of tumours will be possible with CTL induced on a stable source of tumour antigen.Keywords
This publication has 24 references indexed in Scilit:
- Long-term serum/plasma-free culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cellsCancer Immunology, Immunotherapy, 1994
- Cytotoxic T-cell memory without antigenNature, 1994
- In Vitro Expansion of Tumor-Specific, HLA-Restricted Human CD8+ Cytolytic T LymphocytesCellular Immunology, 1994
- Lysis of human pancreatic adenocarcinoma cells by autologous hla‐class I‐restricted cytolytic T‐lymphocyte (CTL) clonesInternational Journal of Cancer, 1993
- Inhibition of Human Colon Cancer Growth by Antibody-Directed Human LAK Cells in SCID MiceScience, 1993
- T Cell Recognition of Human Tumors: Implications for Molecular Immunotherapy of CancerClinical Immunology and Immunopathology, 1993
- A molecular model of MHC class-I-restricted antigen processingImmunology Today, 1992
- Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene TransductionNew England Journal of Medicine, 1990
- Functional evidence for the recognition of endogenous peptides by autoreactive T cell clonesInternational Immunology, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987